Gina Consylman

2018 - Ironwood Pharmaceuticals

In 2018, Gina Consylman earned a total compensation of $1.9M as Chief Financial Officer and Senior Vice President at Ironwood Pharmaceuticals, a 98% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$207,500
Option Awards$501,764
Salary$415,000
Stock Awards$782,385
Other$8,040
Total$1,914,689

Consylman received $782.4K in stock awards, accounting for 41% of the total pay in 2018.

Consylman also received $207.5K in non-equity incentive plan, $501.8K in option awards, $415K in salary and $8K in other compensation.

Rankings

In 2018, Gina Consylman's compensation ranked 5,968th out of 14,244 executives tracked by ExecPay. In other words, Consylman earned more than 58.1% of executives.

ClassificationRankingPercentile
All
5,968
out of 14,244
58th
Division
Manufacturing
2,269
out of 5,759
61st
Major group
Chemicals And Allied Products
848
out of 2,122
60th
Industry group
Drugs
709
out of 1,811
61st
Industry
Pharmaceutical Preparations
552
out of 1,385
60th
Source: SEC filing on April 26, 2019.

Consylman's colleagues

We found five more compensation records of executives who worked with Gina Consylman at Ironwood Pharmaceuticals in 2018.

2018

Peter Hecht

Ironwood Pharmaceuticals

Chief Executive Officer

2018

William Huyett

Ironwood Pharmaceuticals

Chief Operating Officer

2018

Mark Currie

Ironwood Pharmaceuticals

Chief Scientific Officer

2018

Thomas McCourt

Ironwood Pharmaceuticals

President

2018

Halley Gilbert

Ironwood Pharmaceuticals

Chief Administrative Officer

News

You may also like